The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
Geng Liu(Guizhou University), Nicholas B. La Thangue(Northeast Catholic College)
Cited by 16
Related Papers
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
|Immunology and Cell Biology|2011|443
Atypical E2F activity restrains APC/C <sup>CCS52A2</sup> function obligatory for endocycle onset
|Proceedings of the National Academy of Sciences|2008|183
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
|Nature Communications|2023|115
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism
|Cancer Research|2016|44
MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor
|Molecular Medicine Reports|2016|33